As patients achieve weight loss with Semaglutide GLP-1, they will begin to observe not only the weight loss itself but also associated health benefits such as increased energy levels, improved mood, and better sleep
Another 2024 study, involving more than 400,000 patients in the Netherlands, found that people with Type 2 diabetes who used semaglutide had more than double the risk of developing NAION compared to those who didnt take the drug
Cons: Many compounds are insufficiently tested in clinical trials and are yet to be approved for human use
Medicare GLP-1 Bridge Program, Insurance, and How Omzo Fits In Starting July 1, 2026, eligible Medicare beneficiaries can get select FDA-approved GLP-1 medications - Wegovy, Foundayo, and Zepbound KwikPen - for $50 per month through the CMS Medicare GLP-1 Bridge Program
It supports nerve health, cognitive function, and methylation pathways